phase readout
saveNCT07108153: Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta
ACTIVE_NOT_RECRUITINGupdated 10d ago
community read0 votes
Sponsor: Sionna Therapeutics Inc.. Phase: PHASE2. Conditions: Cystic Fibrosis (CF)
view source ↗
comments(0)
5-min edit window · permanent after that